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Cyclic adenosine monophosphate (cAMP) has long been re-
garded as a se~ond ~essenger and a regulator of human ker-
atinocyte prohferatlon. It has been demonstrated that cAMP 
inhibits keratinocyte proliferation when used at high con-
centrations. Nevertheless, new recent reports have demon-
strated that cAMP may stimulate or inhibit keratinocyte 
gro"Wth depe~ding upon the concentration. use~. Studies to 
examine the mfluence of cAMP upon the mlgratIOn of other 
cell types have been contradictory. To determine the di.rect 
effect of dibutyryl cAMP (DBcAMP) upon human keratmo-
cyte mig~ation, we used a quantitative l?comotion assay 
using a wlde range of DB cAMP concentr~tIons. We.fou~d a 
bi-phasic effect of DBcAMP on keratmocyte mlgrat~on 
across connective tissue matrices. Keratinocyte 10comotlOn 
on the matrices was promoted at 10-5 M and 10-6 M of 
T he process of wound healing includes coagulation of blood products, formation of a fibrin clot, inflamma-tion, re-epithelialization, angiogenesis, wound con-traction, connective tissue repair, and remodeling [1,2]. Re-epithelialization involves two mechanisms. 
First, there is a rapid migration ofkeratinocytes over the wound bed. 
Second, epidermal cell proliferation occurs within 48 - 72 h after 
the epidermal cells migrate [2] . Therefore, both keratinocyte mi-
gration and c~1I division maY'play. iH?portant roles in re-epitheliali-
zation. Keratmocyte mIgration IS mfluenced by the connective 
tissue matrix to which the cells are apposed [3]. For example, 
matrices of type I collagen, type IV collagen, and fibronectin dra-
matically promote keratinocyte locomotion, whereas laminin, a 
large basement membrane zone glycoprotein, uniquely inhibits it 
[3-5]. 
Soluble compounds that directly affect keratinocyte locomotion 
are less well defined. Transforming growth factor-beta (TGF-P) has 
been shown to promote the epidermal outgrowth of split-thickness 
explant cultures [6]. However,. this is a comple~ ~ulture . system 
containing fibroblasts, endothehal cells, and dendnttc cells m addI-
tion to keratinocytes. In addition to the possible occurrence of cell-
cell interactions, the explant outgrowth phenomenon is a compos-
ite of cellular division and motility. 
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DB cAMP , but not at higher or lower concentrations. Time-
course experiments demonstrated that the effect of DB cAMP 
on keratinocyte locomotion and proliferation occurred inde-
pendently. Fluorescence-activated cell sorter analysis dem-
onstrated that the effect of DEcAMP on the migration of 
human keratinocytes was independent from the modulation 
of integrin receptors. Although the cellular mechanisms by 
which DBcAMP promotes keratinocyte migration is un-
clear, the addition of DBcAMP or TPA to keratinocyte cul-
tures enhanced the synthesis of a 92-kDa metalloproteinase 
in association with enhanced cellular migration. These ob-
servations suggest a possible link between metalloproteinase 
expression and cellular migration.] Imlest D ermatol1 02:891 -
897, 1994 
High concentrations of intracellular cyclic adenosine monophos-
phate (cAMP) or the exogenous addition of dibutyryl cAMP 
(DBcAMP) to keratinocyte explant cultures have been reported to 
inhibit epidermal outgrowth [7,8]. Because these experiments used 
explant cultures [7] or ex vivo assays [8], it is difficult to evaluate the 
direct effect of these agents on keratinocytes. As noted above, these 
sy~tems cannot discern the relative contributions made by cell mo-
tIhty and cell division. 
Using a pure keratinocyte culture system, Green [9] reported 
3 X 10- 5 M DBcAMP enhances human keratinocyte proliferation. 
Falanga et al [10] also demonstrated that DBcAMP can stimulate 
the proliferative potential of normal human keratinocytes. Thus, 
DB~AMP has been shown to modulate human keratinocyte prolif-
er.atlon. Moreover, DBcAMP applied topically to human wounds 
stimulates wound healing [11] . However, whether the DBcAMP 
effect on wounds is due to an influence on cell division, cell motility 
or both is not known. 
In this study, we evaluated the direct effect of DB cAMP on kerat-
inocyte locomotion using a phagokinetic track assay in which cellu-
lar migration is quantitated by computerized image analysis [3] . In 
parallel, we examirted the time sequence of the DBcAMP influence 
on the proliferative potential of human keratinocytes usirtg the thy-
midine incorporation assay of O'Keefe and Chiu [12] . To determine 
the cellular mechanisms by which DB cAMP influences keratino-
cy~e migration, we examined the expression of keratinocyte inte-
gnn receptors with or without the presence of DBcAMP using 
fluorescence-activated cell sorter (FACS) analysis. Petersen et al [13] 
demonstrated that 12-0-tetradecanoyl phorbol-13-acetate (TP A) 
dramatically enhanced keratinocyte collagenase. Other studies 
[14-16] showed that keratinocyte-derived collagenases were en-
hanced when the cells were stimulated to migrate. Therefore, we 
evaluated the influences of both DB cAMP and TPA on keratino-
cyte migration and expression of metalloproteinases. 
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MATERIALS AND METHODS 
Cell Culture Human keratinocytes from neonatal foreskin were initiated 
into cul ture by the method of Rheinwald and Green [17] . Keratinocytes 
were harvested, plated, and subcultured in low calcium, serum-free KGM 
(keratinocyte growth medium, Clonetics, San Diego, CAl by the method of 
Boyce and Ham [1 8] as modified by Chiu and O'Keefe [19]. Cultures were 
passaged twice to remove any contaminating fibroblasts, as previously de-
scribed [13]. 
Matrix Molecules and Materials DBcAMP, TPA, type I collagen, and 
pepsinized human placental type IV collagen were purchased from Sigma 
Chemicals (St. Louis, MO). Human plasma fibronectin was obtained from 
GIBCO Laboratories (Grand Island, NY). Rat monoclonal antibody to Pl 
(A2B2), mouse monoclonal antibody to a2 (VM1), and mouse monoclonal 
antibody to a6 (GOH3) integrin subunits were generous gifts from Dr. 
Randall Kramer at the University of California at San Francisco. Mouse 
monoclonal antibodies to a3 (PIB5) and as (PIB6) integrin subunit were 
applied by Telios Inc. (San Diego, CAl. Fluorescein isothiocyanate (FITC)-
conjugated goat anti-mouse IgG and goat anti-rat IgG were purchased from 
Jackson Immuno Res (Bar Harbor, ME). These antibodies were used in 
FACS analysis experiments (vide infra). 
Migration Assays A modification of the phagokinetic track assay of Al-
brecht-Buehler [20] was established for human keratinocytes. Pure cell loco-
motion was quantitated by computer-assisted image analysis as previously 
described [3]. Briefly, coverslips were coated with colloidal gold salts and 
placed in 12-well dishes (Corning). The coverslips were then washed with 
2 ml of Hanks' balanced salt solution (HBSS) supplemented with calcium 
and magnesium. Extracellular matrix molecules at various concentrations 
(0 -90 ttg/ml) were added in 0.8 ml ofHBSS with calcium and magnesium 
and incubated for 2 h at 37°C. Sixty to seventy percent of radioactively 
labeled matrix molecules were bound to the coverslips after vigorous wash-
ing [3]. Four thousand keratinocytes were plated in each well (816 cells/ 
cm2) in serum-free KGM. Cultures were incubated for 16-24 or 48 h, 
washed, and fixed in 3% formaldehyde in phosphate-buffered saline (PBS). 
A Jandel Video Analysis computer system was used for quantitative analy-
sis of keratinocyte locomotion. Five random, non-overlapping fields from 
each dish were. captured by the computer and the percentage of the total field 
area taken up by migration tracks was calculated for each field. The percent-
age of total field area taken up by migration tracks was defined as the 
migration index (MI). Each condition was assayed in duplicate. 
The KGM group without added DBcAMP or TPA was treated as the 
control baseline group within each experimental set. The MIs for each 
DBcAMP or TPA concentration were determined. Each MI represents the 
mean track area divided by the field area from at least ten non-overlapping 
fields viewed by the video camera and analyzed by the computer. The 
percent difference between the Mis of those assays performed in the presence 
of DBcAMP or TPA and those assays without the addition of these factors 
(i.e., control baseline group) was calculated over a wide range of different 
concentrations. 
Statistical Analysis Results were evaluated using the Student t test. MIs 
between the basel ine control group (KGM group without DBcAMP or 
TPA) and each concentration of DBcAMP or TPA group were compared. 
The level of significance was defined as p < 0.05. 
Thymidine Incorporation Assay For the evaluation of the effect of 
DB cAMP on keratinocyte proliferative potential, we used the thymidine 
incorporation assay for keratinocytes described by O'Keefe and Chiu [12]. 
All assays were performed in 24-well Corning trays with 4 ttg/ml of type I 
collagen using 1 ml of KGM with or without the addition of DBcAMP. 
Keratinocytes were incubated in KGM with each concentration of 
DBcAMP for 24 or 48 h. 
After incubation with DBcAMP, 2 ttC i of3H-thymidine (ICN Laborato-
ries, Irvine, CAl was added to each well and pulsed for 6 h. Keratinocytes 
were washed twice with cold PBS and then washed once with ice-cold 5% 
trichloroacetic acid. Keratinocytes were solubilized by 0.1 % sodium dode-
cylsulfate (SDS). Solubilized radioactivity was counted in a scintillation 
counter with Safety Solve (Research Products International, Mount Pros-
pect, IL). Each group of thymidine incorporation assay was composed of six 
wells. 
FACS Analysis for Integrin Receptor Subunits Keratinocytes were 
incubated with or without DBcAMP for 16 h. Keratinocytes were then 
incubated with phosphate-buffered saline (PBS) containing 2 mM ethylene 
diaminetetraacetic acid for 30 min and 1 X 105 cells were resuspended in 
PBS with 1 % fetal bovine serum per condition. Cells were incubated with 
primary antibodies to the integrin receptor subunits (1 : 100, final concentra-
tion) for 60 min at 4 ° C. Then, cells were incubated with FITC-conjugated 
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secondary antibody (1 : 100) for 20 min at 4°C. The cells were fixed witb 
0.5% formaldehyde in PBS and FACS analysis was done using FACStar or 
FACScan (Becton Dickinson Immunocytometry Systems Inc., San Jose, 
CAl flow cytometer. 
Zymogram Analysis of Type IV Collagenase/Gelatinase Zymo-
gram analysis was performed according to the method described previously 
[16]. Briefly, conditioned media from cultured keratinocytes incubated with 
or without DBcAMP or TPA for 24 h was suspended in loading dye (0.25 M 
Tris-HCI, pH 6.8, 5% SDS, 0.1 % bromophenol blue, 4% sucrose). Samples 
were not reduced or heated, and were loaded on a 10% SDS polyacrylamide 
gel containing 0.1 % gelatin. Following electrophoresis, the gel was soaked 
in 2.5% Triton X-I00 for 30 min at room temperature and subsequently 
incubated in 0.05 M Tris containing 5 mM calcium chloride at 37"C for 
48 h. The gels were stained for 1 h with Coomassie brilliant blue and then 
destained. 
Enzyme-Linked Immunosorbant Assay (ELISA) for Interstitial 
Collagenase Keratinocyte conditioned media with or without DBcAMP 
were directly assayed for collagenase activity using ELISA [21] . Samples 
were incubated with rabbit anti - type I collagenase antibody (a generous gift 
from Eugene A. Bauer, M.D., Department of Dermatology, Stanford Uni-
versity, Stanford, CAl at 4°C overnight, then incubated with goat anti-rab-
bit IgG-alkaline phosphatase conjugate (diluted 1 : 1000) at 37°C for 1 h. 
Optical densities were measured at 410 nm by an ELISA reader after color 
development. 
RESULTS 
Keratinocyte Migration Withont Matrix Keratinocytes ap-
posed to covers lips without extracellular matrices exhibited mini-
mal locomotion. The cells made very small round halo-shaped 
tracks. The MIs of keratinocytes apposed to the coverslips without 
matrix components were 1.7 ± 0.6 (mean ± SEM). The presence 
of DB cAMP had no effect on the migration of keratinocytes ap-
posed to coverslips without extracellular matrix molecules. 
Keratinocyte Migration On Collagen Matrices In contrast, 
human keratinocytes demonstrated vigorous migration when ap-
pose~ to a matrix of interstitial (type I) collagen. The migrating 
keratmocytes m ade oblong and long linear tracks in addition to 
some halo-shaped tracks. MIs of keratinocytes migrating on inter-
stitial collagen were 16.4 ± 1.3 when 4 Jlg/ml of collagen was 
absorbed to the dishes. When 15 Jlg/ml of collagen was absorbed to 
the dishes , the migrating keratinocytes produced higher MIs 
(33.7 ± 2.7). When the keratinocytes were apposed to an intersti-
tial collagen matrix, the presence of DBcAMP altered the level of 
migration depending upon the concentration used (Fig 1A,B) . 
C?n a "suboptimal" matrix of type I collagen (4 Jlg/ml), concen-
tratIOns of DB cAMP between 10- 6 M and 10-5 M significantly 
enhanced human keratinocyte locomotion over that of control ker-
atinocytes by 46% (p < 0.05) and 53% (p < 0 .05), respectively (Fig 
1A,B). When the concentration was increased to 10-3 M, locomo-
tion was actuaIly reduced. However, this high concentration of 
DB cAMP is toxic to human keratinocyte cultures [10]. Very dilute 
concentrations (10- 8 M and 10- 7 M) had minimal influence on the 
migration of keratinocytes apposed to collagen. 
When an "optimal" type I collagen matrix was provided (15 
Jlg/ml), DBcAMP at 10-6 M also significantly enhanced the kerati-
nocyte migration by 32% (p < 0 .05) over the control assays with-
out DBcAMP (Fig 2B). However, all other concentrations of 
DBcAMP did not alter the migration of human keratinocytes on an 
"optimal" type I collagen matrix to a statistically significant level. 
Similar to an interstitial collagen matrix, human keratinocytes 
apposed to basement membrane (type IV) collagen demonstrated 
high levels of migration. On a "suboptimal" matrix of type IV 
collagen (4 Jlg/ml), the MIs were 7 .5 ± 0.4. The migration was 
greater (MIs = 13.9 ± 1.8) on an "optimal" type IV collagen ma-
trix (15 Jlg/ml). 
When the keratinocytes were apposed to an "optimal" type IV 
collagen matrix, the presence of DBcAMP at concentrations of 
10- 6 M and 10- 5 M significantly increased migration by 72% (p < 
0.05) and 60% (p < 0.05), respectively, when compared to control 
assays without DBcAMP (Fig 2A,B) . Other concentrations of 
DBcAMP did not alter keratinocyte migration on basement mem-
VOL. 102, NO.6 JUNE 1994 
l 
X 
w 
a 
z 
z 
0 
;:::: 
< 
cx: 
<!l 
::. 
::J 
zO 
0CX: -~ ~z 
<0 
~o 
-,.. 
::'0 
~ 
40 r-------------------------------, 
A 
20 
a 
0 10-8 10-7 10-6 10-5 10-4 10-3 
200 
B 
150 
100 
5ry L-__ L-__ L-__ L_~L_~ __ ~ __ ~ __ ~ 
o 10-8 10-7 10-6 10-5 10-4 10-3 
DeCAMP (M) 
Figure 1. Effect of DB cAMP on human keratinocyte locomotion on "sub-
optimal" concentrations (4 ,ug/ml) of type I and type IV collagen. Cover 
slips were coated with colloidal gold salts and placed in 12-well dishes. Four 
micrograms per milliliter of type I or IV collagens were added and incubated 
for 2 h at 37°C. Human keratinocytes (4 X 103 cells/cm2) were plated in 
each well in KGM cultured for 16 h and fixed in 3% formaldehyde in PBS. 
Keratinocyte migration tracks were measured by computerized image analy-
sis (see Materials and Methods). Ten different fields were analyzed per condi-
tion. Results were evaluated with the Student t test. MIs on type I collagen in 
the presence of various concentrations of DBcAMP is shown in A . B shows 
the percent difference between the MIs of the experimental dishes contain-
ing DBcAMP and the control dishes on type I collagen (open circles) and type 
IV collagen (closed circles) . Bar, mean MIs from at least 10 non-overlapping 
fields. Error bars, SEM . • P < 0.05. 
brane collagen significantly. Likewise, when a "suboptimal" matrix 
of type IV collagen (4 ).lg/ml) was used, DBcAMP did not signifi-
cantly alter migration (Fig IB). 
The effect of TPA on keratinocyte migration was evaluated by 
the addition of 10 ng/ml of TPA to keratinocytes apposed to a 
matrix of type I collagen (4 ).lg/ml) for 16 h. This concentration of 
TP A has been demonstrated to increase the constitutive synthesis of 
collagenase by human keratinocytes in culture [13] . TPA also 
changes the cell morphology of human eridermal carcinoma cells 
and alters protein kinase C expression [22 . Keratinocyte migration 
on type I collagen was enhanced by 40% when the cells were ex-
posed to 10 ng/ml ofTPA (Fig 3). 
~gration on Matrix Glycoproteins Laminin is a major non-
collagenous glycoprotein in basement membranes [23]. Fibronectin 
is a major glycoprotein found inrlasma and in a number of connec-
tive tissues including dermis [24 . Both human fibroblasts and kera-
tinocytes synthesize fibronectin [25,26] and laminin [27]. It has 
been shown previously that a matrix of fibronectin induces human 
keratinocyte migration, whereas a laminin matrix inhibits it 
[3]. Preliminary experiments demonstrated that the fibronectin-
induced migration is concentration dependent and that a plateau is 
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Figure 2_ Effect of DB cAMP on human keratinocyte locomotion on "opti-
mal" concentrations (15 ,ug/ ml) of type I and type IV collagen. The experi-
mental methods were identical to those in Fig 1. The results were evaluated 
with the Student t test. In A, the average MIs of cell migrating on type IV 
c~llagen with and without DB cAMP are demonstrated. In B, the percent 
difference between the MIs of the experimental dishes containing DBcAMP 
and the control dishes (those without DBcAMP) is shown for each situation. 
Bar, mean MIs from at least 10 non-overlapping fields. Error bars, SEM. 
• p < 0.05. 
reached when 60 ).lg/ml of fibronectin is absorbed to the coverslips. 
For the experiments here, we selected a suboptimal amount of 
fibronec~lIl of20 ).lg/ml, which provides MIs approximately 50% of 
the maXimal level. As shown in Fig 4A,B, the only concentration of 
DBc:'--MP that enhanced keratinocyte migration on a fibronectin 
~atnx v.:as a concentration of 10-5 M. When an optimalfibronec-
tlIl matnx (60 ).lg/ml) was used, DBcAMP did not significantly 
promote migration at any of the concentrations tested (data not 
shown) . 
L~minin inhibits keratinocyte locomotion, and the inhibition is 
maXimal at 90 ).lg/ml [4]. At the concentrations tested, DBcAMP 
neither significantly increased or decreased keratinocyte migration 
on a laminin matrix (data not shown). 
Time Course ofKeratinocyte Migration Versus Proliferative 
Potential Induced by DB cAMP To determine when the effect 
of DBcAMP 011 keratinocyte migration occurred, time-course ex-
periments were performed in which human keratinocytes were ap-
posed to an optimal matrix of type I collagen and the levels 
of migration assessed with or without the presence of 10- 5 M 
DBcAMP at 24 and 48 h . As shown in Fig 5, keratinocyte migration 
on type I collagen without the presence of DBcAMP is approxi-
mately the same at 24 and 48 h. Compared with the assays per-
formed without DBcAMP, the presence of DB cAMP in the dishes 
enhances keratinocyte migration by 40% at 24 h (p < 0.05). 
Within this time frame, there is no DBcAMP effect on cell prolifer-
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Figure 3. Effect of TPA on keratinocyte locomotion on type I collagen. 
Four micrograms per milliliter of type I collagen were added to the cover-
slips, and the wells were incubated for 2 hat 37"C. The methods were then 
identical to those in Fig 1, except that, rather than the addition of DB cAMP, 
keratinocytes were incubated for 16 h with or without 10 ng/ml of TPA. 
Results were evaluated with the Student t test. Bar, mean MIs from at least 10 
non-overlapping fields . Error bars, SEM .• P < 0.05. 
ation as judged by the thymidine incorporation assay (vide infra) . In 
the standard migration assay, the keratinocytes have essentially 
stopped migrating between 24 and 30 h. We observed little or no 
enhancement of keratinocyte migration with or without the pres-
ence of DBcAMP at 48 h. Therefore, DB cAMP provided no fur-
ther enhancement in keratinocyte migration between the 24-h and 
48-h period. It appears that most of the enhanced migration due to 
the presence of DBcAMP occurs within the first 24 h. However, 
during the period between 24 and 48 h when keratinocyte migra-
tion was not enhanced, this is the time period when DBcAMP 
induced an enhancement in the proliferative potential of the cells 
(vide infra) . 
DBcAMP has been shown to increase the proliferative potential 
of human keratinocytes [10] . To examine when the effect of 
DBcAMP upon the proliferative potential of human keratinocytes 
ocurred, we performed the thymidine incorporation assay of 
O'Keefe and Chiu [12] on keratinocyte cultures at 24 and 48 h 
using the concentrations of DB cAMP indicated in Fig 6. As shown 
in Fig 6, at 24 h none of the concentrations of DBcAMP tested 
increased the proliferative potential of the cells. However, by 48 h, 
the presence of 10- 5 M of DBcAMP significantly enhanced kerati-
nocyte incorporation of thymidine above that of controls. 
Integrin Receptor Expression Five different 0' subunits and 
two /3 subunits of integrin receptors are recognized in human skin 
[28]. The known ligand of the 0'2 subunit is collagen. The ligands 
for the 0'3 subunit include laminin, collagen, and epiligrin. The 0'5 
subunit recognizes fibronectin. The 0'6//34 integrin complex is lo-
cated within hemidesmosomes [29]. The /31 and 0'3 integrin recep-
tor subunits were highly expressed in keratinocytes with or without 
DBcAMP. The 0'2, 0'5, and 0'6 integrin receptor subunits were 
moderately expressed on normal human keratinocytes with or 
without DBcAMP. However, the presence of DBcAMP did not 
modulate the expression of any of the integrin receptors on kerati-
nocytes (Fig 7). 
Collagenase Expression Exogenous addition of collagenase has 
been shown to enhance the motility of some tumor cells [30] . 
Human keratinocytes constitutively produce and secrete type I col-
lagenase and 72- and 92-kDa type IV collagenases [13-16] . The 
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Figure 4. Effect of DBcAMP on keratinocyte locomotion on matrices of 
fibronectin (20 ,ug/ml) and bovine serum albumin (control). The methods 
were otherwise identical to those in Fig 1. Results were evaluated with the 
Student t test. The matrices to which the cells are apposed in A are fibronec-
tin (dark bars) or albumin (light bars). In B, the cells were apposed to matrices 
of fibronectin (open circles) or albumin (closed circles) . The percent difference 
of the MIs between experimental assays (containing DBcAMP) and control 
assays (without DBcAMP) are demonstrated for both matrices. Bar, mean of 
MIs from at least 10 non-overlapping fields. Error bars, SEM. • P < 0.05. 
control and DBcAMP groups of keratinocyte cultures both synthe-
sized and secreted 72- and 92-kDa type IV collagenase by zymo-
graphy analysis (Fig 8a) . There was no difference in the expression 
of 72-kDa type IV collagenase between control and DBcAMP 
groups. However, the presence of 10-4 and 10-6 M concentrations 
of DBcAMP promoted the expression of the 92-kDa type IV colla-
genase by the keratinocytes as compared to control. The addition of 
TP A to the cultures also enhanced the expression of both the 92-
and 72-kDa type IV collagenase in a dose-dependent fashion (Fig 
8b). The concentrations of type I collagenase in keratinocyte culture 
media range between 12.0 and 16.9 ng/ml, values which are 40 to 
60 times lower than those of fibroblasts extracts [21]. The presence 
of DBcAMP in the cultures did not alter the secretion of type I 
collagenase as measured by ELISA (data not shown). These results 
suggest that the 92-kDa type IV collagenase is specifically in-
fluenced by the addition of DBcAMP. 
DISCUSSION 
cAMP acts as a second messenger of the cells [31]' and the elevation 
of intracellular cAMP by the exogenous addition of DBcAMP to 
cells or tissues mediates various kinds of actions such as the dilata-
tion of peripheral vessels, the enhancement of glycogenolysis, and 
the inhibition of platelet aggregation [32] . Most of the studies in-
volving cAMP and keratinocytes have focused on cellular prolifera-
tion. There are no studies that have evaluated the direct effect of 
DBcAMP on human keratinocyte migration. 
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Figure 5. Human keratinocyte locomotion on type I collagen after 24 and 
48 h. Migration assays performed at 24 and 48 h with 1O-s M of DB cAMP 
(striped bars) or without DBcAMP (white bars). Bar, mean of Mis from at least 
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However, the effect of cAMP on cell locomotion has been studied 
in several other cell types using cAMP-elevating agents such as 
DBcAMP [33], cholera toxin [34], or p-receptor stimulants [35J. 
Most of these studies show an inhibition of cell locomotion by an 
elevation of intracellular cAMP. For example, cholera toxin and 
insulin inhibit the locomotion of 3T3 cells [34]; retinal pigment 
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Figure 6. Effect of DBcAMP on 3H-thymidine incorporation (prolifera-
tive potential) after 24 and 48 h of incubation. Keratinocytes were incubated 
on 4,ugjml of type I collagen in KGM with each concentration of DB cAMP 
for 24 or 48 h. After the incubation with DBcAMP, 2 ,uCi oflH-thymidine 
was added to each well and pulsed for 6 h. Keratinocytes were washed with 
PBS and 5% trichloracetic acid. Cells were solubilized by 0.1 % SDS. Solubi-
lized radioactivity was counted in a scintillation counter. Each point on the 
graph represents six identical assays. The mean values of each experimental 
situation were compared with parallel control assays in which no DBcAMP 
was added. The percentage difference of thymidine incorporation between 
the experimental and control assays are demonstrated at 24 h (closed circles) 
and 48 h (opetr circles). 
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Figure 7. Effect of DB cAMP on the expression ofintegrin receptor subunit 
by FACS analysis. Keratinocytes were incubated with or without DB cAMP 
for 1~ h. Cells w~re incubated with antibody to each integrin receptor 
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Cells were analyzed by a fluorescence activated cell sorter. Horizotllallines, 
intensity of fluorescence; vertiea/lilles, number of cells. The number enclosed 
within in each graph is the modal fluorescence value. 
epithelial cell migration is inhibited by DBcAMP [33] . Similarly, 
spontaneous motility of rabbit peritoneal neutrophils is inhibited by 
a number of substances that elevate cAMP [36]. However, there 
have been few reports on the assessment of the effect of DBcAMP 
on keratinocyte locomotion. Using the wound closure of newt 
liu:bs, Donaldson et al [37] suggested that the effect of cAMP on 
epidermal cell migration depends on its concentration. Stenn and 
Depalma [2] support this notion and suggest that cAMP at specific 
concentrations may modify the movement of keratinocytes. 
. Our exp~ri~ents show that DBcAMP at appropriate concentra-
tIOns can slgmficantly enhance the migration of keratinocytes on 
connective tissue matrices of fibronectin, interstitial collagen, and 
baseme~t membrane collagen. The enhancement is biphasic be-
cause high and low concentrations of DB cAMP have either no 
e~ect or a slight suppressive effect upon keratinocyte locomotion. 
HI~h concentrations of DB cAMP (l0-3M) are toxic to human ke-
ratll10cytes [10]. Falanga et at [10] also reported that DBcAMP stim-
ulated the proliferation ofkeratinocyte cultures at concentrations of 
10- 5 M and 10- 6 M and suppressed keratinocyte proliferation at 
~ 0~3 M . We believe that this explains why keratinocyte locomotion 
IS either unaltered or slightly suppressed when high concentrations 
of DBcAMP are used. When low concentrations of the DBcAMP 
are used, we believe that locomotion is not altered because the agent 
is .too dilute to exert a biologic effect. Like keratinocytes, dermal 
rrucrovascular endothelial cells proliferate in a bi-phasic manner to 
c.oncentrations of DB cAMP [38]. Our experiments on cell migra-
Clon show that the effect of DBcAMP on keratillocyte locomotion 
has a similar bi-l.'hasic effect. 
Sarret et at [39J have shown that human keratinocyte locomotion 
and keratinocyte cellular division occur by independent mecha-
nisms. The results here support this notion. The enhancement of 
896 IWASAKI ET AL 
92 kOa 
72 kOa 
92 kOa 
72 kOa 
A 
OSCAMP(M) 
-4 -6 -8 
o 0 10 10 
o 
TPA 
1 
(ng/ml) 
5 1 0 
8 
Figure 8. Zymograms of conditioned medium from keratinocytes cultured 
for 24 h on type I collagen in the presence of DB cAMP (A) orTPA (B). The 
white ballds on each zymogram are proteins in the medium with metallopro-
teinase activity. The effects of DB cAMP and TPA on type IV collagenase 
expression human keratinocytes in zymography. A, keratinocytes were cul-
tured on 4 Jig/ml of type I collagen in the presence of 10-4 M, 10- 6 M, 
10-8 M, or no DBcAMP. The media samples (equalized for protein content) 
were analyzed by zymography. Arrows, positions of a 92-kDa and a 72-kDa 
type IV collagenase. B, the expression of a 92- and a 72-kDa type IV colla-
genase when cells were incubated with 0,1,5, or 10 ng/ml ofTPA. The 
92-kDa and 72-kDa arrows indicate the positions of the 92-kDa and 72-kDa 
type IV collagenases. 
keratinocyte migration by the presence of DBcAMP occurs pre-
dominantly within the first 24 h. In contrast, DBcAMP does not 
invoke an augmentation in the proliferative potential of the cells 
until 48 h. This is in accordance with the studies of Falanga et at [10] 
who demonstrated that the enhancement ofkeratinocyte growth by 
DBcAMP occurs at 48 h. Taken together, the parallel locomotion 
and thymidine incorporation studies suggest that DBcAMP pro-
motes keratinocyte locomotion independently from its effects on 
cell division. DBcAMP promotes keratinocyte locomotion in the 
first 24 h of culture, at a time when no effect upon the proliferative 
potential of the cells can be observed. 
In our study, the time-course experiments demonstrated that the 
DBcAMP enhancement of keratinocyte migration occurred within 
the first 24 h. Within the first 24-h period, DBcAMP does not alter 
the thymidine incorporation of the cells (Fig 6). During this period, 
however, the cells are migrating and the presence of DB cAMP 
enhances this migration (Fig 5). The effect of DB cAMP upon thy-
midine incorporation (the proliferative potential of the cells) occurs 
later, after 24 h, at a time when the cells have stopped migrating 
(Fig 6). Therefore, the DBcAMP effect upon keratinocyte migra-
tion can act independently from the DBcAMP influence upon the 
proliferative potential of the cells. 
Human keratinocyte locomotion on extracellular matrices such 
as fibronectin, interstitial collagen, and basement membrane colla-
gen may be mediated by integrin receptors [40]. Blocking the a2p1 
integrin receptor inhibited keratinocyte migration on collagen ma-
trices but not on fibronectin. Blocking aSp1 integrin receptor in-
hibited keratinocyte migration on fibronectin but not on collagen 
[40]. These findings show that the a2 or as integrin receptor sub-
units contribute to the keratinocyte migration on collagen matrices 
or fibronectin, respectively. The a3p1 integrin uniquely enhanced 
migration on fibronectin and collagen [40]. Because these studies 
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showed that integrins may playa role in keratinocyte migration, we 
examined the effect of DBcAMP on the integrin receptor expres-
sion using FACS analysis. However, the presence of DB cAMP was 
found not to alter the expression of integrin receptors on cultured 
keratinocytes. The enhancement of keratinocyte locomotion by 
DB cAMP appears to be independent of integrin expression. 
Terranova et al [30] showed that migration of human oral squa-
mous cell carcinoma cells (SCC-4) was enhanced by type IV colla-
genase derived from conditioned medium of SCC-4 cells and the 
collagenase inhibitor, SC-44483, inhibited the motility of SCC-4 
cells in a dose-dependent manner. These data suggested that type IV 
collagenase may directly enhance the motility of tumor cells. This 
has not been shown to occur in cells with a non-malignant pheno-
type. However, the experiments reported here show that DBcAMP 
stimulates the synthesis and secretion of the 92-kDa type IV colla-
genase although leaving the expression of the 72-kDa enzyme and 
type I collagenase unaltered. Moreover, the induction of keratino-
cyte collagenase by TP A that enhances protein kinase C was asso-
ciated with enhanced keratinocyte migration. Taken together, 
these experiments suggest that one mechanism by which DBcAMP 
may stimulate keratinocyte migration is related to the enhanced 
secretion of type IV collagenase. 
Another striking result of these studies was the interaction of the 
DBcAMP effect with the extracellular matrix effect. For example, 
DBcAMP could not exert an effect on migration when the kerati-
nocytes were apposed to either a suboptimal (4 J.lg/ml) matrix of 
basement membrane (type IV) collagen or an optimal (60 J.lg/ml) 
matrix of fibronectin. We do not understand the mechanisms in-
volved in the interactions between the cells, matrix and soluble 
factors that account for these observations. However, it may be that 
when cells are maximally stimulated to migrate by an optimal fibro-
nectin matrix that no further migration can be invoked by the 
addition of DBcAMP on this particular matrix. Alternatively, for 
DBcAMP to have an effect on the migration of keratinocytes on 
basement membrane collagen, they must be provided with an opti-
mal matrix. It is conceivable that DBcAMP adsorbs itself to the type 
IV collagen and in some way becomes more accessible to the cells. 
Whatever the mechanism involved, it appears that keratinocyte 
locomotion can be modulated by the interactions of soluble factors 
and matrix working in the same direction. Moreover, it is likely that 
in vivo, keratinocyte migration is ultimately modulated by a combi-
nation of soluble factors and extracellular matrix. 
Tllis study was supported by grams AR33625, POt AR4t045, alld AROt540 
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